413 related articles for article (PubMed ID: 9407028)
21. Lack of c-Jun activity increases survival to cisplatin.
Sánchez-Pérez I; Perona R
FEBS Lett; 1999 Jun; 453(1-2):151-8. PubMed ID: 10403393
[TBL] [Abstract][Full Text] [Related]
22. Selective interaction of JNK protein kinase isoforms with transcription factors.
Gupta S; Barrett T; Whitmarsh AJ; Cavanagh J; Sluss HK; Dérijard B; Davis RJ
EMBO J; 1996 Jun; 15(11):2760-70. PubMed ID: 8654373
[TBL] [Abstract][Full Text] [Related]
23. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
24. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
25. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter.
Kaminuma O; Deckert M; Elly C; Liu YC; Altman A
Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617
[TBL] [Abstract][Full Text] [Related]
26. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
27. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.
Wilson KE; Li Z; Kara M; Gardner KL; Roberts DD
J Immunol; 1999 Oct; 163(7):3621-8. PubMed ID: 10490955
[TBL] [Abstract][Full Text] [Related]
28. A radicicol-related macrocyclic nonaketide compound, antibiotic LL-Z1640-2, inhibits the JNK/p38 pathways in signal-specific manner.
Takehana K; Sato S; Kobayasi T; Maeda T
Biochem Biophys Res Commun; 1999 Apr; 257(1):19-23. PubMed ID: 10092503
[TBL] [Abstract][Full Text] [Related]
29. Dose rate and mode of exposure are key factors in JNK activation by UV irradiation.
Adler V; Polotskaya A; Kim J; Dolan L; Davis R; Pincus M; Ronai Z
Carcinogenesis; 1996 Sep; 17(9):2073-6. PubMed ID: 8824537
[TBL] [Abstract][Full Text] [Related]
30. CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation.
Li W; Whaley CD; Bonnevier JL; Mondino A; Martin ME; Aagaard-Tillery KM; Mueller DL
J Immunol; 2001 Jul; 167(2):827-35. PubMed ID: 11441089
[TBL] [Abstract][Full Text] [Related]
31. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1.
Yang SH; Whitmarsh AJ; Davis RJ; Sharrocks AD
EMBO J; 1998 Mar; 17(6):1740-9. PubMed ID: 9501095
[TBL] [Abstract][Full Text] [Related]
32. Coactivator CBP in the regulation of conceptus IFNtau gene transcription.
Xu N; Takahashi Y; Matsuda F; Sakai S; Christenson RK; Imakawa K
Mol Reprod Dev; 2003 May; 65(1):23-9. PubMed ID: 12658630
[TBL] [Abstract][Full Text] [Related]
33. Integration of MAP kinase signal transduction pathways at the serum response element.
Whitmarsh AJ; Shore P; Sharrocks AD; Davis RJ
Science; 1995 Jul; 269(5222):403-7. PubMed ID: 7618106
[TBL] [Abstract][Full Text] [Related]
34. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
35. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons.
Schwarzschild MA; Cole RL; Hyman SE
J Neurosci; 1997 May; 17(10):3455-66. PubMed ID: 9133371
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells.
Hirasawa N; Sato Y; Fujita Y; Mue S; Ohuchi K
J Immunol; 1998 Nov; 161(9):4939-43. PubMed ID: 9794429
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
38. Coordinate activation of activator protein 1 and inflammatory cytokines in response to Neisseria gonorrhoeae epithelial cell contact involves stress response kinases.
Naumann M; Rudel T; Wieland B; Bartsch C; Meyer TF
J Exp Med; 1998 Oct; 188(7):1277-86. PubMed ID: 9763607
[TBL] [Abstract][Full Text] [Related]
39. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.
Behre G; Whitmarsh AJ; Coghlan MP; Hoang T; Carpenter CL; Zhang DE; Davis RJ; Tenen DG
J Biol Chem; 1999 Feb; 274(8):4939-46. PubMed ID: 9988737
[TBL] [Abstract][Full Text] [Related]
40. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade.
Kempiak SJ; Hiura TS; Nel AE
J Immunol; 1999 Mar; 162(6):3176-87. PubMed ID: 10092768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
